Paulash Mohsen
Chief Executive Officer at Vesigen, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Peters | M | 61 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 3 years |
| Marie N. Epstein | F | - |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | 6 years |
| Douglas Lankler | M | 58 | 25 years | |
| Sally Susman | F | 62 | 17 years | |
| Dieter Weinand | M | 63 |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 7 years |
| Suzanne Johnson | F | 66 | 17 years | |
| Markus Green | M | - | 18 years | |
| Mike McDermott | M | 58 | 21 years | |
| Payal Sahni Becher | F | - | 27 years | |
| Stephen Bruso | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
| Lucio Iannone | M | 41 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
| Denis Patrick | M | - | 14 years | |
| Jürgen Eckhardt | M | 57 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
| Suneet Varma | M | 55 | 23 years | |
| Mikael Dolsten | M | 65 | 15 years | |
| Jak Knowles | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
| Brigitte Robertson | M | - |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| David Arkowitz | M | 62 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Lok Chung Chan | M | 73 |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | 4 years |
| Jeffery Kelly | M | 63 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Richard Heyman | M | 66 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Kimberlee Drapkin | F | 55 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| N. Coles | M | 63 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Cecil B. Pickett | M | 78 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Barbara Dalton | M | 69 | 17 years | |
| Lynne Zydowsky | M | 65 |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | - |
| Annaliesa Anderson | M | - | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert A. Millman | M | - |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | - |
| Henry McKinnell | M | 81 | 8 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| Dennis Ausiello | M | 78 | 13 years | |
| George A. Lorch | M | 82 | 15 years | |
| Amy Schulman | F | 63 | 6 years | |
| David Shedlarz | M | 75 | 31 years | |
| John Mascotte | M | 84 | 4 years | |
| Patricia Allen | F | 62 | - | |
| Mace Rothenberg | M | 67 | 13 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Martin MacKay | M | 68 | 14 years | |
| Alan Levin | M | 62 | 20 years | |
| Robert Landry | M | 60 | 4 years | |
| Paul Fitzhenry | M | 63 | 4 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Devin Smith | M | 56 | - | |
| Ranjeev Krishana | M | 50 | 7 years | |
| Jonathan Emms | M | - | 20 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Jennifer Schroeder | F | - | 20 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| Michael Wyzga | M | 35 | - | |
| Wyllie Cornwell | M | 76 | 23 years | |
| Freda Lewis-Hall | M | 69 | 11 years | |
| George Milne | M | 80 | 32 years | |
| Dana George Mead | M | 88 | 12 years | |
| Stephen W. Sanger | M | 78 | 9 years | |
| Peter Corr | M | 76 | 6 years | |
| Frances Fergusson | M | 79 | 9 years | |
| William Herbert Gray | M | 82 | 13 years | |
| Robert N. Burt | M | 86 | 11 years | |
| James Kilts | M | 76 | 13 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Robert Zerbe | M | 73 | 7 years | |
| Cara Cassino | M | 62 | 5 years | |
| Lisa Ricciardi | F | 64 | - | |
| Yacoub Habib | M | 56 | 2 years | |
| David Roth | M | 61 | 4 years | |
| Michael Bruce | M | - | 12 years | |
| Angela Hwang | F | 58 | 26 years | |
| John Porter | M | 53 | 5 years | |
| Karin Jooss | M | 59 | 7 years | |
| Robyn Peters | F | - | 4 years | |
| Walter S. Hauck | M | 64 | 13 years | |
| Ian Taylor | M | 61 | 9 years | |
| Glenn Miles | M | 58 | 4 years | |
| John W. Poyhonen | M | 64 | 7 years | |
| Brian Krex | M | 57 | 9 years | |
| Victor Micati | M | 83 | 34 years | |
| Robert E. Grasty | M | 55 | - | |
| Scott Cheshareck | M | - | 16 years | |
| Kim Seth | M | - | 3 years | |
| Eliot Forster | M | 58 | 11 years | |
| John Henderson | M | 79 | - | |
| Feargal Mooney | M | 54 | 3 years | |
| John F. Niblack | M | 85 | 35 years | |
| Wesley W. Day | M | 59 | 12 years | |
| Catherine Mackey | M | 68 | 11 years | |
| Frank Sciavolino | M | 83 | 35 years | |
| Julie A. Olson | M | - | 19 years | |
| James Bristol | M | 77 | 4 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Loretta Ucelli | F | - | - | |
| George W. Evans | M | 70 | 26 years | |
| Tanya Clemons | M | - | - | |
| Tatyana Daniels | F | - | - | |
| Thomas G. Gant | M | - | 6 years | |
| James H. Heym | M | - | 24 years | |
| Howard Mayer | M | 62 | 7 years | |
| James New | M | 70 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paulash Mohsen
- Personal Network
